| Literature DB >> 22107883 |
Tsong-Rong Jang1, Ching-Lin Wu, Chai-Ming Chang, Wei Hung, Shih-Hua Fang, Chen-Kang Chang.
Abstract
Many athletes need to participate in multiple events in a single day. The efficient post-exercise glycogen recovery may be critical for the performance in subsequent exercise. This study examined whether post-exercise carbohydrate supplementation could restore the performance in the subsequent simulated wrestling match. The effect of branched-chain amino acids and arginine on glucose disposal and performance was also investigated. Nine well-trained male wrestlers participated in 3 trials in a random order. Each trial contained 3 matches with a 1-hr rest between match 1 and 2, and a 2-hr rest between match 2 and 3. Each match contained 3 exercise periods interspersed with 1-min rests. The subjects alternated 10-s all-out sprints and 20-s rests in each exercise period. At the end of match 2, 3 different supplementations were consumed: 1.2 g/kg glucose (CHO trial), 1 g/kg glucose + 0.1 g/kg Arg + 0.1 g/kg BCAA (CHO+AA trial), or water (placebo trial). The peak and average power in the 3 matches was similar in the 3 trials. After the supplementation, CHO and CHO+AA trial showed significantly higher glucose and insulin, and lower glycerol and non-esterified fatty acid concentrations than the placebo trial. There was no significant difference in these biochemical parameters between the CHO and CHO+AA trials. Supplementation of carbohydrate with or without BCAA and arginine during the post-match period had no effect on the performance in the following simulated match in wrestlers. In addition, BCAA and arginine did not provide additional insulinemic effect.Entities:
Year: 2011 PMID: 22107883 PMCID: PMC3286371 DOI: 10.1186/1550-2783-8-21
Source DB: PubMed Journal: J Int Soc Sports Nutr ISSN: 1550-2783 Impact factor: 5.150
Figure 1Study protocol. ■: 1-min rest; ↑: supplementation; ▲: blood sampling.
Peak and average power in 3 matches in the 3 trials1
| Placebo trial | CHO trial | CHO+AA trial | |
|---|---|---|---|
| Peak power | |||
| 1st match (W/kg) | 70.36 ± 3.38 | 71.24 ± 4.19 | 72.62 ± 4.59 |
| 2nd match (W/kg) | 69.45 ± 5.40 | 69.05 ± 5.42 | 72.08 ± 6.14 |
| 3rd match (W/kg) | 67.49 ± 4.81 | 68.72 ± 4.84 | 72.52 ± 8.18 |
| Average power | |||
| 1st match (W/kg) | 61.97 ± 3.33 | 63.90 ± 3.82 | 64.24 ± 4.14 |
| 2nd match (W/kg) | 61.41 ± 4.84 | 61.05 ± 4.59 | 63.48 ± 5.54 |
| 3rd match (W/kg) | 59.27 ± 4.15 | 60.89 ± 4.42 | 63.85 ± 7.09 |
| Drop in peak power | |||
| Match 1 - Match 2 (%) | 1.93 ± 5.07 | 3.35 ± 4.36 | 1.49 ± 4.14 |
| Match 1 - Match 3 (%) | 4.62 ± 3.93 | 3.52 ± 3.75 | 2.17 ± 6.61 |
| Drop in average power | |||
| Match 1 - Match 2 (%) | 1.28 ± 5.18 | 4.58 ± 4.23 | 2.00 ± 4.14 |
| Match 1 - Match 3 (%) | 4.54 ± 4.10 | 4.65 ± 4.04 | 2.59 ± 6.45 |
1 Each trial contained 3 matches with a 1-hr rest between match 1 and 2 and a 2-hr rest between match 2 and 3. A match contained 3 exercise periods lasting 2 minutes each with a work to rest ratio of 10 seconds: 20 seconds. After each exercise period, a 2 minute rest period was provided before the next exercise period. The load was 0.1 kp/kg body weight. All values are means ± SEMs. Data were analyzed by using repeated measures ANOVA with time and group as factors. No significant main effect was observed for any of the variables.
Figure 2Plasma glucose concentrations in the 3 trials. Data were analyzed by using repeated measures ANOVA with time and group as factors. Treatment effect p = 0.006; time effect p < 0.001; interaction effect p < 0.001. *CHO trial significantly different from placebo trial at the same time point (p < 0.05). #CHO+AA trial significantly different from placebo trial at the same time point (p < 0.05).
Figure 3Plasma insulin concentrations in the 3 trials. Data were analyzed by using repeated measures ANOVA with time and group as factors. Treatment effect p = 0.013; time effect p < 0.001; interaction effect p < 0.001. *CHO trial significantly different from placebo trial at the same time point (p < 0.05). #CHO+AA trial significantly different from placebo trial at the same time point (p < 0.05).
Figure 4Plasma glycerol concentrations in the 3 trials. Data were analyzed by using repeated measures ANOVA with time and group as factors. Treatment effect p = 0.262; time effect p < 0.001; interaction effect p < 0.001. *CHO trial significantly different from placebo trial at the same time point (p < 0.05). #CHO+AA trial significantly different from placebo trial at the same time point (p < 0.05).
Figure 5Plasma non-esterified fatty acid concentrations in the 3 trials. Data were analyzed by using repeated measures ANOVA with time and group as factors. Treatment effect p = 0.017; time effect p < 0.001; interaction effect p < 0.001. *CHO trial significantly different from placebo trial at the same time point (p < 0.05). #CHO+AA trial significantly different from placebo trial at the same time point (p < 0.05).
Figure 6Plasma lactate concentrations in the 3 trials. Data were analyzed by using repeated measures ANOVA with time and group as factors. Treatment effect p = 0.546; time effect p < 0.001; interaction effect p = 0.085.
Figure 7Plasma NOx concentrations in the 3 trials. Data were analyzed by using repeated measures ANOVA with time and group as factors. Treatment effect p = 0.533; time effect p = 0.002; interaction effect p < 0.001.